IEFAvsIHE
iShares Core MSCI EAFE ETF against iShares U.S. Pharmaceuticals ETF — the fee, the flows, the book, and a year head-to-head.
Head to head
| IEFA | IHE | |
|---|---|---|
| Expense ratio | 0.070% | 0.40% |
| Assets | $193.2B | $1.7B |
| Net flow, 1 month | +$631M | +$186M |
| Net flow, 1 year | +$17.9B | +$763M |
| Return, YTD | +11.2% | +27.4% |
| Return, 1 year | +16.7% | +54.9% |
| Avg daily volume | 7.6M | 280K |
| Holdings | 2798 | 38 |
| Listed | Oct 17, 2012 | Apr 30, 2006 |
| Options market | Yes | Yes |
MARKED CELLS LEAD ON THAT LINE · LOWER FEE, LARGER ASSETS, STRONGER FLOWS & RETURNS